» Articles » PMID: 31453182

Influence of Mechanochemical Technology on Anthelmintic Efficacy of the Supramolecular Complex of Fenbendazole with Polyvinylpyrrolidone

Overview
Date 2019 Aug 28
PMID 31453182
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of our research was to evaluate the effect of mechanochemical technology on the efficacy of supramolecular complex of fenbendazole (SMCF) with polyvinylpyrrolidone (PVP) polymer against some helminthosis of animals.

Materials And Methods: The SMCF samples with PVP were synthesized using a solid-state mechanochemical technology in activators of impact-abrading type and their physicochemical properties were analyzed. The efficacy of SMCF was studied on the laboratory model of and infection of mice and helminthosis of sheep.

Results: In the trials conducted on laboratory models, the supramolecular complex showed 93.94% and 98.56 % efficacy at the dose of 1 mg/kg of body weight (b/w), while the substance of fenbendazole showed 7.97% and 8.33% efficacy at the same dose. A high efficacy (>94%) of the SMCF was revealed at the dose of 2.0 mg/kg of b/w at oral administration against nematodes in naturally infected sheep by the results of the fecal examination, while the substance of fenbendazole was active at the dose of 5.0 mg/kg at single oral administration. Moreover, the SMCF demonstrated 97.37% efficacy at the dose of 2 mg/kg against spp. infection of sheep. Physicochemical studies confirmed the increase in solubility of the complex, reducing of particle sizes, amorphization of fenbendazole substance, and incorporating it with micelles of PVP.

Conclusion: According to the results, supramolecular complex of fenbendazole with PVP was more active than the basic substance of fenbendazole and its anthelmintic properties were expanded.

Citing Articles

Preparation and evaluation of fenbendazole methyl-β-cyclodextrin inclusion complexes.

Ding Y, Zhang Z, Ding C, Xu S, Xu Z BMC Vet Res. 2024; 20(1):214.

PMID: 38769544 PMC: 11103997. DOI: 10.1186/s12917-024-04056-1.


Micro-Injection Moulding of PEO/PCL Blend-Based Matrices for Extended Oral Delivery of Fenbendazole.

Bezerra G, De Lima G, Colbert D, Halligan E, Geever J, Geever L Pharmaceutics. 2023; 15(3).

PMID: 36986761 PMC: 10051197. DOI: 10.3390/pharmaceutics15030900.


PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells.

Koohi Moftakhari Esfahani M, Alavi S, Cabot P, Islam N, Izake E Pharmaceutics. 2021; 13(10).

PMID: 34683898 PMC: 8540390. DOI: 10.3390/pharmaceutics13101605.


Efficacy of Novel Formulations of Ivermectin and Albendazole in Parasitic Infections of Sheep in the Altai Mountains of Russia.

Marchenko V, Khalikov S, Efremova E, Ilyin Ju M Iran J Parasitol. 2021; 16(2):199-208.

PMID: 34557234 PMC: 8418662. DOI: 10.18502/ijpa.v16i2.6268.


Anthelmintics for drug repurposing: Opportunities and challenges.

Alavi S, Ebrahimi Shahmabadi H Saudi Pharm J. 2021; 29(5):434-445.

PMID: 34135669 PMC: 8180459. DOI: 10.1016/j.jsps.2021.04.004.


References
1.
Steel J, Hennessy D . Influence of ruminal bypass on the pharmacokinetics and efficacy of benzimidazole anthelmintics in sheep. Int J Parasitol. 1999; 29(2):305-14. DOI: 10.1016/s0020-7519(98)00156-8. View

2.
Kang J, Kumar V, Yang D, Roy Chowdhury P, Hohl R . Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. Eur J Pharm Sci. 2002; 15(2):163-70. DOI: 10.1016/s0928-0987(01)00214-7. View

3.
Rogero S, Malmonge S, Lugao A, Ikeda T, Miyamaru L, Cruz A . Biocompatibility study of polymeric biomaterials. Artif Organs. 2003; 27(5):424-7. DOI: 10.1046/j.1525-1594.2003.07249.x. View

4.
Lukyanov A, Torchilin V . Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev. 2004; 56(9):1273-89. DOI: 10.1016/j.addr.2003.12.004. View

5.
Le Garrec D, Gori S, Luo L, Lessard D, Smith D, Yessine M . Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J Control Release. 2004; 99(1):83-101. DOI: 10.1016/j.jconrel.2004.06.018. View